- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03664583
ACHRU Community Partnership Program for Diabetes Self-Management for Older Adults - Canada (ACHRU-CPP)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Scarborough, Ontario, Canada
- Scarborough Health Network
-
Toronto, Ontario, Canada
- St. Michael's Hospital
-
-
Prince Edward Island
-
Charlottetown, Prince Edward Island, Canada
- University of Prince Edward Island
-
-
Quebec
-
Québec City, Quebec, Canada
- L'Universite Laval
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Patient participants ("CPP Target Population") will be included in the study if they meet the following inclusion criteria:
- Diagnosis of type 1 or type 2 diabetes
- Aged 65+ years
- Enrolled in a primary care organization
- Diagnosed with at least one other chronic condition
- Residing in the area served by the primary care and community site
- Capable of providing informed consent, or has a substitute decision-maker who is able to provide informed consent on his/her behalf
- Competent in English or has an interpreter who is competent in English for Ontario and Prince Edward Island (PEI) study sites. Patient participants that score 5 or higher on The Short Portable Mental Status Questionnaire (SPMSQ) will be eligible as patient participants. Those with scores below 5 will be eligible if they have a proxy decision-maker.
Caregiver participants will be included in the study if they meet the following inclusion criteria:
- Identified by the patient participant as an informal family or friend caregiver
- At least 18 years of age
- Provides physical, emotional, or financial care to the patient participant
- Scores 5 or higher on the SPMSQ
Provider and manager participants will be included in the study if they meet the following inclusion criteria:
- Working with the primary care setting or community partner organization at a study site
- Either a Registered Nurse (RNs) or Registered Dietitian (RDs) at the primary care setting
- A Program Coordinator (PC) from the community partner organization
- A manager of the RN or RD at the primary care setting
- A manager of the PC at the community partner organization
Patient, Public and Community Research Partner participants will be included in the study if they meet the following inclusion criteria:
- Older adult living in the community, or
- Community living family or friend caregiver of a person with a diagnosis of diabetes and one or more chronic condition, or
- Community living health provider or manager of persons with diabetes and one or more chronic condition, or
- A knowledge user (e.g. policy maker) who works in health planning or health policy decision making at the community level representative of study sites
- Persons not receiving the CPP intervention
Exclusion Criteria:
• Patient and caregiver participants in Ontario and PEI who do not speak English and do not have an interpreter/translator
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention Group
Patients randomly assigned to the intervention group will be offered the ACHRU-Community Partnership Program (CPP) intervention in addition to usual primary care services offered by their local diabetes education centre or primary care setting.
The CPP is a 6-month self-management intervention consisting of six core components: 1) home or virtual visits (up to 3) supported by phone calls by either a Registered Nurse (RN) or Registered Dietician (RD); 2) wellness sessions (up to 6, one per month) provided to patients and their caregivers at the location of the community partner or virtually; 3) monthly team case conferences with the provider team; 4) caregiver support; 5) collaboration with the primary care interprofessional team and other specialists; 6) nurse-led care coordination/system navigation.
|
The intervention is a 6-month community navigation and self-management program for patients with diabetes and at least one additional chronic condition, and their caregivers, to improve health outcomes.
The intervention will be provided by an interprofessional team of providers and consists of six core components.
|
No Intervention: Control Group
Those who are randomly assigned to the control group will continue to be offered usual primary care services through their local diabetes education centre or primary care setting.
The services that comprise usual diabetes care vary across the provinces e.g., length and focus of educational sessions, whether classes are strongly recommended versus optional (e.g., foot care, cardiac health, eating and exercise interventions), home visits, access to on-site professionals (e.g., endocrinologist, dietitian, physiotherapist, exercise specialist, pharmacist), connections with support services and community resources, and type of follow-up services available.
Details of usual care provided at each site will be recorded.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mental Health Using the Short-Form 12 Health Survey Version 2 (SF-12v2) - Mental Component Summary score.
Time Frame: Baseline, 6-months
|
The Short-Form 12 Health Survey Version 2 (SF-12v2) tool will be used to assess mental health.
The tool consists of 12 questions that measure functional health and well-being from the participant's perspective.
It provides scores for eight health domains (physical functioning, role-physical, bodily pain, general health, social functioning, role-emotional, mental health), by which a psychometrically-based Physical Component Summary (PCS) and Mental Component Summary (MCS) can be calculated.
Response options include the frequency of feeling a certain way or behaviour across 3 or 5 categories (e.g., 'all of the time'...'none of the time').
Patients and caregivers will be evaluated for change in SF-12-MCS from baseline to 6-months.
Total scale range: 0 - 100.
Higher scores represent better mental functioning.
|
Baseline, 6-months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-Management Using the Summary of Diabetes Self-Care Activities (SDSCA)
Time Frame: Baseline, 6-months
|
The Summary of Diabetes Self-Care Activities (SDSCA) will be used to assess self-management.
The SDSCA is a multidimensional measure of diabetes self-management with adequate internal and test-retest reliability, and evidence of validity and sensitivity to change.
The revised SDSCA consists of 11 items that assess the following aspects of the diabetes regimen: (1) general and specific diet; (2) exercise; (3) blood-glucose testing; (4) foot care; and (5) smoking.
Change in patient self-management will be evaluated using the SDSCA.
Scale range: 0 - 71.
Higher scores represent better self-management.
|
Baseline, 6-months
|
Physical Health Using the Short-Form 12 Health Survey Version 2 (SF-12v2) - Physical Component Summary score.
Time Frame: Baseline, 6-months
|
The Short-Form 12 Health Survey Version 2 (SF-12v2) tool will be used to assess physical health.
The tool consists of 12 questions that measure functional health and well-being from the participant's perspective.
It provides scores for eight health domains (physical functioning, role-physical, bodily pain, general health, social functioning, role-emotional, mental health) by which a psychometrically-based Physical Component Summary (PCS) and Mental Component Summary (MCS) score can be calculated.
Response options include the frequency of feeling a certain way or behaviour across 3 or 5 categories (e.g., 'all of the time'...'none of the time').
Patients and caregivers will be evaluated for change in SF-12-PCS from baseline to 6-months.
Total scale range: 0 - 100.
Higher scores represent better physical functioning.
|
Baseline, 6-months
|
Depressive Symptoms Using the Center for Epidemiologic Studies on Depression 10-Item Scale (CES-D-10)
Time Frame: Baseline, 6-months
|
The Center for Epidemiologic Studies on Depression 10-Item Scale (CES-D-10) will be used to assess depressive symptoms.
This tool has been used in prior studies of older adults with mood disorders, has a high degree of reliability and validity, and is a sensitive tool for measuring changes in depressive symptoms over time.
Participants will be asked about the way they have felt or behaved in response to 10 statements such as 'I was happy'.
Response options ask participants to select the frequency they have felt or behaved during the last week, ranging from 'rarely or none of the time (less than 1 day)', 'some or a little of the time (1-2 days)', 'occasionally or moderate (3-4 days)', to 'most or all of the time (5-7 days)'.
Patients and caregivers will be evaluated for change in depressive symptoms using CES-D-10.
Scale range: 0 - 30.
Higher scores represent more depressive symptoms.
|
Baseline, 6-months
|
Level of Anxiety Using the Generalized Anxiety Disorder 7-Item (GAD-7)
Time Frame: Baseline, 6-months
|
The Generalized Anxiety Disorder 7-Item (GAD-7) will be used to assess anxiety levels.
The GAD-7 is a 7-item tool that asks about the type and frequency of being bothered by a list of problems.
Response options include 'not at all', 'several days', 'more than half the days', or 'nearly every day', over the last two weeks.
Patients and caregivers will be evaluated for change in level of anxiety using GAD-7.
Scale range: 0 - 21. Higher scores represent more anxiety.
|
Baseline, 6-months
|
Physical Activity Using the Physical Activity Scale for the Elderly (PASE)
Time Frame: Baseline, 6-months
|
The Physical Activity Scale for the Elderly (PASE) tool will be used to assess the physical activity of patients.
The PASE measures physical activity over the past 7 days.
It asks about the type and frequency of physical activity across categories of light, moderate and strenuous physical activity.
Patients will be evaluated for change in physical activity using the PASE tool.
Higher scores represent better physical activity.
|
Baseline, 6-months
|
Caregiver Strain Using the Modified Caregiver Strain Index (MCSI)
Time Frame: Baseline, 6-months
|
The Modified Caregiver Strain Index (MCSI) will be used to assess caregiver strain.
This tool will ask caregivers a list of 13 activities that they may have found to be difficult such as sleeping, physical strain, financial strain, personal plans, and work and family adjustments as a result of the caregiver role.
Response options include 'yes' according to two levels, either 'yes, on a regular basis' or 'yes, sometimes', or alternatively, 'no'.
Scale range: 0 - 26.
Higher scores represent more strain.
|
Baseline, 6-months
|
Social Support Using the Abbreviated Duke Social Support Index (DSSI)
Time Frame: Baseline, 6-months
|
The abbreviated, 11-item Duke Social Support Index (DSSI) will be used to measure social support.
This 11-item instrument includes two major sub-scales: a 4-item social interaction sub-scale and a 7-item subjective support sub-scale.
Response options on the social interaction sub-scale ask participants to rate the frequency of their social interactions in the past week: "none", "1-2", ">2", or "0-1 time", "2-5 times", "6 or more times".
Response options on the subjective support sub-scale include "hardly ever", "some of the time", "most of the time", or "very dissatisfied", "somewhat dissatisfied" "satisfied".
Scale range: 11-33.
Higher DSSI scores represent more social support.
|
Baseline, 6-months
|
Functional Status Using the Duke Older Americans Resources and Services Procedures (OARS) Multidimensional Functional Assessment Questionnaire - Activities of Daily Living section
Time Frame: Baseline, 6-months
|
The OARS Multidimensional Functional Assessment Questionnaire is a valid and reliable questionnaire, designed to assess the overall personal functional status and service use of older adults.
Participants will be asked to respond to questions from the Activities of Daily Living section [14-items; activities of daily living (ADLs)/instrumental activities of daily living (IADLs)] of the OARS, which assesses both activities of daily living, such as eating, dressing and walking; and instrumental activities of daily living, such as using a telephone, shopping for groceries, and preparing meals.
Response options include "without help", "with some help", and "completely unable".
Scale range: 0-28.
Higher scores represent a higher level of function.
|
Baseline, 6-months
|
Nutritional Status Using the Seniors in the Community Risk Evaluation for Eating and Nutrition tool (SCREEN II-AB)
Time Frame: Baseline, 6-months
|
The Seniors in the Community Risk Evaluation for Eating and Nutrition tool (SCREEN II-AB) is an abbreviated, 8-item nutrition screening instrument for older adults living in the community, to identify individuals at risk for nutritional problems or who have poor nutritional status.
Items assess for weight change in the past 6 months, intake of fruit, vegetables and fluid, meal consumption and preparation, appetite, and swallowing.
Scale range: 0-52.
Higher scores represent lower risk for nutritional problems.
|
Baseline, 6-months
|
Shared Decision-Making Using the CollaboRATE tool
Time Frame: Baseline, 6-months
|
The CollaboRATE tool consists of 3 items that measure the level of shared decision-making in a clinical encounter from the patient's perspective.
These items are: (i) How much effort was made to help you understand your health issues?
(ii) How much effort was made to listen to what matters most to you about your health issues?
(iii) How much effort was made to include what matters most to you in choosing what to do next?
Participants are asked to rate their last appointment, on a 10-point scale from 0=No effort was made, to 9=Every effort was made.
Scale range: 0-27.
Higher scores represent a higher degree of shared decision-making.
|
Baseline, 6-months
|
Service Use Using the Health and Social Services Utilization Inventory (HSSUI)
Time Frame: Baseline, 6-months
|
The Health and Social Services Utilization Inventory (HSSUI) will be used to assess service use of patients and caregivers.
The HSSUI is a reliable and valid self-report questionnaire that measures the use of health and social services from a societal perspective.
The HSSUI provides information on different categories of use including acute care service use such as emergency department visits and hospitalizations, use of nursing and allied health professionals, and visits to family doctors and specialists.
As part of the HSSUI, diabetes and other medications, supplies and devices will also be assessed.
Change in the use of health and social services will be assessed for patients and caregivers using the HSSUI.
Patients (not caregivers) will be assessed for medication use using the HSSUI.
|
Baseline, 6-months
|
Glycated hemoglobin (HbA1c)
Time Frame: Baseline, 6-months
|
Patients will be evaluated for glycated hemoglobin (HbA1c) as abstracted from their medical records.
Values closest to the time frame will be used.
|
Baseline, 6-months
|
Glomerular Filtration Rate (GFR)
Time Frame: Baseline, 6-months
|
Patients will be evaluated for glomerular filtration rate (GFR) as abstracted from their medical records.
Values closest to the time frame will be used.
|
Baseline, 6-months
|
Low-Density Lipoprotein (LDL)
Time Frame: Baseline, 6-months
|
Patients will be evaluated for low-density lipoprotein (LDL) as abstracted from their medical records.
Values closest to the time frame will be used.
|
Baseline, 6-months
|
Collaboration Using the Partnership Self-Assessment Tool (PSAT)
Time Frame: 6-months
|
The Partnership Self-Assessment (PSAT) will be used to assess the collaboration process.
The PSAT tool has shown acceptable validity and reliability.
Questions ask about different aspects of the partnership, and the strengths and weaknesses of the collaboration process involved in the partnership (e.g., synergy, leadership, efficiency, administration and management etc.).
Providers and managers will be evaluated for change in collaboration.
Scale range: 1 - 5. Lower scores represent a lower level of collaboration.
|
6-months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Maureen Markle-Reid, RN, PhD, McMaster University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KPG 156883
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Medical College of WisconsinMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Medical College of WisconsinMedical University of South Carolina; National Institute of Diabetes and Digestive...Active, not recruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical College of WisconsinNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
Clinical Trials on ACHRU-Community Partnership Program (CPP)
-
New York UniversityActive, not recruiting
-
San Diego State UniversityFamily Health Centers of San DiegoRecruitingSARS-CoV-2 InfectionUnited States
-
Johns Hopkins UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruiting
-
Evidation HealthHumana Co.Ltd.CompletedDiabetes Mellitus, Type 2United States
-
University of RochesterEunice Kennedy Shriver National Institute of Child Health and Human Development...Active, not recruiting
-
University of Dublin, Trinity CollegeRecruitingPhysical InactivityIreland
-
National Cancer Center, KoreaSamsung Medical Center; Asan Medical Center; Seoul National University Hospital; Korea University Anam Hospital and other collaboratorsUnknownBreast Cancer | Gastric Cancer | Lung Cancer | Colon CancerKorea, Republic of
-
The University of Texas Health Science Center,...CompletedSocial Determinants of HealthUnited States
-
University of California, San FranciscoSeva Foundation; Bharatpur Eye HospitalCompletedGlaucoma | Diabetic Retinopathy | Refractive Errors | Cataract | Age Related Macular DegenerationNepal
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)RecruitingCancer Education | Spanish Language Cancer EducationUnited States, Puerto Rico